Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases  by Banin, Sharon et al.
Wiskott–Aldrich syndrome protein (WASp) is a binding partner
for c-Src family protein-tyrosine kinases
Sharon Banin*†, Oan Truong†, David R. Katz‡, Michael D. Waterfield†§, Paul M.
Brickell* and Ivan Gout†
Background: Receptor-mediated signal transduction requires the assembly of
multimeric complexes of signalling proteins, and a number of conserved protein
domains, such as the SH2, SH3 and PH domains, are involved in mediating
protein–protein interactions in such complexes. The identification of binding
partners for these domains has added considerably to our understanding of
signal-transduction pathways, and the purpose of this work was to identify SH3-
binding proteins in haematopoietic cells. 
Results: We performed affinity-chromatography experiments with a panel of
GST–SH3 fusion proteins (composed of glutathione-S-transferase appended to
various SH3 domains) to search for SH3-binding proteins in a human
megakaryocytic cell line. Protein microsequencing identified one of the SH3-
binding proteins as WASp, the protein that is defective in Wiskott–Aldrich
syndrome (WAS) and isolated X-linked thrombocytopenia. WASp bound
preferentially in vitro to SH3 domains from c-Src family kinases, and analysis of
proteins expressed in insect cells using a baculovirus vector demonstrated a
specific interaction between WASp and the Fyn protein-tyrosine kinase. Finally,
in vivo experiments showed that WASp and Fyn physically associate in human
haematopoietic cells.
Conclusions: Haematopoietic cells from individuals with WAS exhibit defects in
cell morphology and signal transduction, including reduced proliferation and
tyrosine phosphorylation in response to stimulatory factors. Members of the
c-Src family of protein-tyrosine kinases, including Fyn, are involved in a range of
signalling pathways — such as those regulating cytoskeletal structure — in both
haematopoietic and non-haematopoietic cells. Our data suggest that binding of
Fyn to WASp may be a critical event in such signalling pathways in
haematopoietic cells.
Background
Signal transduction through cell-surface receptors
involves the assembly of multimeric complexes of cyto-
plasmic signalling proteins. Amongst the structural ele-
ments responsible for the protein–protein interactions
that hold these complexes together are SH2 and SH3
domains [1]. These were first described as non-catalytic
domains of members of the c-Src family of cytoplasmic
protein-tyrosine kinases (PTKs), but were subsequently
found in a large number of other signalling proteins [2].
Some of these — such as the p85 subunit of phos-
phatidylinositol 3′-kinase (PI 3-kinase), phospholipase C-
g1 (PLC-γ1), Ras GTPase-activating protein (RasGAP)
and phosphotyrosine phosphatase 1C (PTP1C) — have
associated enzyme activities that are important in signal
transduction. Others, such as Grb2, Shc, c-Crk1 and Nck,
have no associated enzyme activity but act as adaptors
that couple other proteins together. Yet others, like
a-spectrin, are cytoskeletal proteins.
SH2 domains bind with high affinity to selected phospho-
tyrosine-containing proteins [1]. Although phosphotyrosine
is an essential component of SH2-binding sites, the sur-
rounding amino acids are important in determining the
affinity of binding, so particular SH2 domains show speci-
ficity for distinct phosphotyrosine-containing peptides [1].
SH3 domains bind to proline-rich sequences that form type
II left-handed helical structures, and there is specificity in
the binding of different SH3 domains to such sequences
[1]. To investigate the function of SH3-mediated interac-
tions, a number of groups have searched for SH3-binding
proteins by screening cDNA expression libraries with
labelled SH3 domains [3], by affinity chromatography fol-
lowed by protein microsequencing [4], or by yeast two-
hybrid screens [5]. SH3-binding proteins that have been
identified include 3BP1 [3], dynamin [4], synapsin I [6],
the epithelial sodium channel aENaC [7] and the guanine
nucleotide-exchange factors Sos [8] and C3G [9]. Analyses
of these proteins suggest that SH3 domains are involved in
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diverse signalling pathways. For example, Grb2 binds via
its two SH3 domains to proline-rich motifs in Sos, thereby
coupling receptor PTKs to Ras [8], whereas binding of
aENaC to the SH3 domain of a-spectrin seems to mediate
its localization to the apical membrane of epithelial cells
[7]. Using a different approach, mutational analysis of SH3
domains of c-Src family kinases has indicated that they may
be involved in negative regulation of the kinase activity of
these proteins [10].
SH3-containing proteins have been implicated in a
number of diverse signalling pathways in haematopoietic
cells, including those triggered by receptor PTKs and by
transmembrane receptors that lack kinase activity, such as
B-cell and T-cell receptors and Fc receptors [11,12].
However, relatively little is known about the haematopoi-
etic cell proteins that bind to SH3 domains in these sig-
nalling pathways. In this paper we report the use of a
panel of SH3 domains in affinity-chromatography experi-
ments to identify such proteins. Amongst the SH3-
binding proteins we identified was WASp, the protein
defective in the X-linked immunodeficiency disorder
Wiskott–Aldrich Syndrome (WAS) [13] that has recently
been linked to signalling pathways involving the Cdc42
GTPase [14,15]. WASp bound preferentially to SH3
domains from c-Src family kinases, and in vivo studies
showed that WASp bound specifically to Fyn and, to a
lesser extent, to c-Fgr. These results suggest a link
between WASp and protein-tyrosine kinases in signal
transduction in haematopoietic cells.
Results and discussion
Affinity purification of SH3-binding proteins
To identify SH3-binding proteins in the human
megakaryocytic cell line CHRF, we incubated cell lysates
with a panel of GST–SH3 fusion proteins (made up of the
amino-acid sequence of glutathione-S-transferase (GST)
fused to sequences encoding various SH3 domains). After
extensive washing, bound proteins were analyzed by
SDS–PAGE and visualized by Coomassie staining. Figure
1 shows that each GST–SH3 domain bound to a specific
selection of proteins. However, the binding profile was
found to be very similar for different members of the c-Src
family of kinases. In particular, the most prominent of the
proteins binding to the SH3 domains of c-Src, Fyn and c-
Fgr was a doublet of 65/68 kDa. Binding of this doublet to
SH3 domains from PI 3-kinase p85a subunit, PLC-g and
Grb2 was also just discernible (Fig. 1). These interactions
were strong enough to resist washing in buffer containing
a high concentration of salt and detergent. Similar analysis
of other cell lysates showed that this doublet was present
in a range of haematopoietic cell lines but absent from
epithelial and fibroblast cell lines (data not shown). In
view of the important roles of c-Src family kinases in
haematopoietic cells, we were encouraged to purify and
characterize p65/68.
The p65/68 SH3-binding protein is WASp
To identify the p65/68 SH3-binding proteins, we first per-
formed large scale affinity purification from cell extracts of
the U937 human monoblastic leukaemia cell line, because
these cells were found to contain high levels of p65/68
(Fig. 2). U937 cells also contained another prominent
SH3-binding protein of approximately 44 kDa (Fig. 2).
Microgram quantities of p65 and p68 were excised from
the SDS–PAGE gel and digested with lysoendopeptidase
C. Generated peptides were resolved by high-pressure
liquid chromatography and their amino-acid sequences
determined. As shown in Figure 3a, some of the peptides
were common to both p65 and p68, suggesting that the
two proteins were closely related. 
Searches of the protein databases showed that all of the
peptides generated from p68 were identical to equivalent
sequences in WASp (Fig. 3b), the recently identified
product of the WAS gene at Xp11.22-p11.23, which is
defective in people with WAS and isolated X-linked
thrombocytopenia [16–21]. However, only six of the eleven
peptides generated from p65 matched WASp sequences.
The remaining peptides showed no significant homology
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Figure 1
Binding of proteins from CHRF cells to a panel of GST–SH3 fusion
proteins. CHRF cell lysate was incubated with glutathione–
Sepharose beads coupled to GST alone or to GST fused to SH3
domains from the p85a subunit of PI3 kinase, PLC-g, Ras GAP, c-Src,
the p47 subunit of NADPH oxidase (amino-terminal SH3 domain,
p47-N), the p67 subunit of NADPH oxidase (amino-terminal SH3
domain, p67-N; carboxyl-terminal SH3 domain, p67-C), c-Crk, c-Fgr,
spectrin, Grb2 (amino-terminal SH3 domain, N-Grb2; carboxyl-terminal
SH3 domain, C-Grb2; full-length Grb-2), Fyn and Csk. Bound proteins
were eluted, analyzed by SDS–PAGE and visualized by staining with
Coomassie blue. The position of the p65/68 kDa doublet and
GST–SH3 fusion proteins are indicated.
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to WASp or to any proteins in the database. It is possible
that the affinity-purified 65 kDa band contained more than
one protein, one of which was WASp. Alternatively, p65
could be an isoform of WASp, perhaps encoded by an alter-
natively spliced mRNA.
Analysis of the in vitro association between WASp and a
panel of SH3 domains by immunoblotting
To further characterize the interaction between WASp and
SH3 domains, we raised a polyclonal rabbit antiserum (SK3)
against a carboxy-terminal peptide corresponding to amino
acids 487–501 of WASp [13]. This antiserum was affinity
purified using a carboxy-terminal peptide–Actigel matrix.
In immunoblotting experiments, affinity-purified SK3 anti-
bodies specifically recognized a U937 cell protein of
approximately 68 kDa, which bound to GST–Fgr-SH3 but
not to GST alone (Fig. 4). SK3 antibodies did not recognize
p65 (Fig. 4), suggesting either that p65 and p68 differ at
their carboxyl termini, or that differences elsewhere in the
proteins result in different conformations at their carboxyl
termini. Further confirmation of the specificity of affinity-
purified SK3 antibodies came from their ability to bind to
WASp expressed using a baculovirus expression system
(see below). SK3 antibodies were not able to immuno-
precipitate WASp from cell lysates.
We used affinity-purified SK3 antibodies in immunoblot-
ting experiments to re-examine the binding of WASp to
the panel of GST–SH3 fusion proteins. Silver staining
(Fig. 4a) and immunoblotting analysis (Fig. 4b) clearly
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Figure 2
Binding of p65/68 from U937 cell lysates to a GST fusion protein
containing the c-Fgr SH3 domain (GST–Fgr-SH3). U937 cell lysates
were in incubated with glutathione–Sepharose beads coupled to
GST alone or to GST–Fgr-SH3. Bound proteins were eluted,
analyzed by SDS–PAGE and visualized by staining with Coomassie
blue. The positions of the p65/68 kDa doublet, an SH3-binding
protein of approximately 44 kDa, the GST–Fgr-SH3 fusion protein
and GST are indicated by arrows. M, molecular weight markers.
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(a) Amino-acid sequences of peptides (single-letter code) obtained
from lysoendopeptidase C digest of p65 and p68. Sequences shown
in red are found in WASp. The identities of the amino acids shown in
parenthesis are uncertain; ‘X’ denotes unknown amino acids. (b)
Alignment of p65 and p68 peptides (in red) with the amino-acid
sequence of WASp (in black) [13].
1 MSGGPMGGRP GGRGAPAVQQ NIPSTLLQDH ENQRLFEMLG RKCLTLATAV
51 VQLYLALPPG AEHWTKEHCG AVCFVKDNPQ KSYFIRLYGL QAGRLLWEQE
EHXG AVXFVK
101 LYSQLVYSTP TPFFHTFAGD DCQAGLNFAD EDEAQAFRAL VQEKIQKRNQ
RNQ
151 RQSGDRRQLP PPPTPANEER RGGLPPLPLH PGGDQGGPPV GPLSLGLATV
RQSGDRRQLP PPGTSA
201 DIQNPDITSS RYRGLPAPGP SPADKKRSGK KKISKADIGA PSGFKHVSHV
ADIGA PSGFKHVSHV
251 GWDPQNGFDV NNLDPDLRSL FSRAGISEAQ LTDAETSKLI YDFIEDQGGL
GWDPQN LI YDFIEDQGFL
301 EAVRQEMRRQ EPLPPPPPPS RGGNQLPRPP IVGGNKGRSG PLPPVPLGIA
EAVRQEMR GRSG PLPPVPLGIA
351 PPPPTPRGPP PPGRGGPPPP PPPATGRSGP LPPPPPGAGG PPMPPPPPPP
PPPPT
401 PPPPSSGNGP APPPLPPALV PAGGPGPGGG RGALLDQIRQ GIQLNKTPGA
TPGA
451 PESSALQPPP QSSEGLVGAL MHVMQKRSRA IHSSDEGEDQ AGDEDEDDEW
PESSALQPPP QSSEGLVGAL MHVMQ
501 DD
p68
F77 TPGAPESSALQPPPQSSEGLVGALMHVMQ
F76 HVSHVGWDPQN
F80 GRSGPLPPVPLGIAPPPPT
F37 ADIGAPSGFK
p65
F37 ADIGAPSGFK
F43 EHXGAVXFVK
F71 RNQRQSGDRRQLPP(P)GT(S)A
F69 LIYDFIEDQGFLEAVRQEMR
F76 TPGAPESSALQPPPQ
F76 HVSHVG
F77 PFELGLEFPNLPYYID
F68 GAGAGGPLP
F35 TVTNDRSAPILDK
F46 LARNESRSGSNR(R)E
F48 TEQAGXNALLSDISK
(a) (b)
confirmed our original observation that WASp binds pref-
erentially to SH3 domains in c-Src, Fyn and c-Fgr, and, to
a lesser extent, to the SH3 domains of PLC-g, Grb2 and
the p85a subunit of PI 3-kinase. In the case of Grb2,
WASp bound to the amino-terminal SH3 domain rather
than the carboxy-terminal SH3 domain, and binding was
retained in full-length Grb2 protein.
Cell distribution of WASp
Total cell lysates from various cell lines were resolved by
SDS–PAGE, immunoblotted and incubated with anti-
WASp (SK3) antibodies. WASp was expressed in all
haematopoietic cell lines tested, including U937, Raji,
HFB1, Jurkat, H9, HPBALL, CHRF and HL60, but was
not expressed in any of the epithelial, myoblast and
fibroblast cell lines that were examined (Fig. 5 and data
not shown). These results suggest that WASp expression
is restricted to cells of haematopoietic lineages. This paral-
lels earlier studies of the distribution of WAS mRNA [13].
WASp associates specifically with Fyn in insect cells
To determine whether the ability of WASp to bind to
isolated SH3 domains in vitro reflected an ability to bind
to full-length SH3-containing proteins in vivo, we first
cloned the full-length WASp coding region into a bac-
ulovirus transfer vector. The recombinant virus directed
high-level expression of WASp in Sf9 insect cells, as
judged by its immunoreactivity with anti-WASp (SK3)
antibodies and its ability to bind to the GST–Fgr-SH3
fusion protein. The electrophoretic mobility of the
expressed WASp corresponded to that of the 68 kDa
protein detected in haematopoietic cells by immunoblot-
ting (data not shown). We also constructed a baculovirus
encoding human c-Fgr (data not shown) and used bac-
uloviruses encoding human c-Src or human Fyn. We co-
expressed WASp with c-Src, Fyn or c-Fgr by co-infecting
Sf9 cells with the appropriate baculoviruses. Three days
after infection, cells were lysed and immunoprecipita-
tions performed using an immunoprecipitating anti-
WASP antiserum (JD1) [15]. To determine whether
c-Src, Fyn or c-Fgr were present in the immunoprecipi-
tates, we first performed immune complex kinase assays
and looked for autophosphorylated c-Src, Fyn or c-Fgr by
SDS–PAGE. As shown in Figure 6a, anti-WASp
immunoprecipitates from cells co-infected with WASp
and Fyn viruses contained protein kinase activity. The
major co-precipitated phosphoprotein co-migrated with
Fyn that was immunoprecipitated from the co-infected
cells by an anti-Fyn antiserum (Fig. 6a). Immunoblotting
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Figure 4
Binding of proteins from U937 cells to a panel of GST–SH3 fusion
proteins. U937 cell lysate was incubated with glutathione–Sepharose
beads coupled to GST alone or to GST fused to SH3 domains from
the p85a subunit of PI 3-kinase, Ras GAP, PLC-g, c-Src, the p47
subunit of NADPH oxidase (amino-terminal SH3 domain, p47-N), the
p67 subunit of NADPH oxidase (amino-terminal SH3 domain, p67-N;
carboxyl-terminal SH3 domain, p67-C), c-Crk, c-Fgr, spectrin, Grb2
(amino-terminal SH3 domain, N-Grb2; carboxyl-terminal SH3 domain;
C-Grb2; full-length Grb-2), Fyn and Csk. Bound proteins were eluted,
subjected to SDS–PAGE and visualized by silver staining (a) or by
immunoblotting using SK3 antibodies directed against WASp (b). The
positions of p65 and p68 proteins are indicated by the arrows.
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Figure 5
Cell distribution of WASp. Total cell lysates of a range of cell lines were
subjected to SDS–PAGE and immunoblotted using the anti-WASp
antibody SK3. Upper panel: Swiss 3T3; NIH 3T3; Cos1; Hep2; RD157;
Rat1; U937; CHRF-288-11 (human megakaryocytic leukaemia); K562
(human erythroid leukaemia); breast lum (primary human breast luminal
epithelial cells); breast myo (primary human breast myoepithelial cells);
Cal51. MDA-MB453, MDA-MB175, MCF7, T47D, BT20, ZR75-1 and
PMC42 are human breast carcinoma cell lines. Lower panel: U937; Raji
(human B-lymphoma); HFB1 (human plasmacytoma); Jurkat (human T-
cell leukaemia); H9 (human T-cell leukaemia); HPB-ALL (human T-cell
leukaemia). SK3 antibodies also recognized rodent WASp in rodent
haematopoietic cells (data not shown). The visible band is p68.
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of anti-WASp immunoprecipitates using the anti-Fyn anti-
serum confirmed that Fyn co-precipitated with WASp
(Fig. 6b). Anti-WASp immunoprecipitates from cells co-
infected with viruses expressing WASp and c-Fgr also
contained protein kinase activity, but this was significantly
weaker than that seen in WASp–Fyn immunoprecipitates
(Fig. 6a). Anti-WASp immunoprecipitates from cells co-
infected with viruses expressing WASp and c-Src did not
contain any detectable kinase activity (Fig. 6a). We were
unable to detect c-Fgr or c-Src in anti-WASp immunopre-
cipitates by immunoblotting (data not shown). These
results show that WASP can associate in vivo with Fyn
and, much less strongly, with c-Fgr, but not with c-Src. 
WASp and Fyn are physically associated in U937 cells
Anti-WASp immunoprecipitates from U937 cell lysates also
contained kinase activity, and the major co-precipitating
phosphoprotein co-migrated with Fyn upon SDS–PAGE
(Fig. 7). Immunoblotting with a monoclonal anti-Fyn
antibody confirmed that anti-WASp immunoprecipitates
contained Fyn (Fig. 8), demonstrating that WASp and Fyn
are normally associated in U937 cells. 
Conclusions
WAS is characterized by a broad range of clinical abnormal-
ities, including thrombocytopenia, eczema, and increased
susceptibility to infection. Several different immunological
abnormalities have been described and there is an
increased risk of lymphoid malignancy [22]. The gene that
is mutated in WAS has recently been identified [13], and
our results indicate that there is a specific interaction in
vivo between the protein product of this gene (WASp) and
the cytoplasmic protein-tyrosine kinase Fyn, which is
mediated by the SH3 domain of Fyn. This is the first
report of an association between WASp and a tyrosine
kinase in vivo, although WASp has previously been shown
to bind to the adaptor protein Nck via its SH3 domains [23]
and to Cdc42 by a mechanism that does not involve SH3
domains [14,15]. The biochemical consequences of these
associations remain to be determined, although our prelim-
inary data suggest that WASp may be phosphorylated, and
the kinase activity of Fyn stimulated, in WASp–Fyn com-
plexes (data not shown). Nevertheless, the fact that WASp
interacts with Cdc42 and Fyn suggests that it may have an
important role in a number of different signalling pathways
in haematopoietic cells, which is consistent with the broad
range of abnormalities seen in WAS.
WASp contains a number of proline-rich motifs that could
behave as SH3-binding sites; these motifs are mostly
located in the carboxyl-terminal half of the protein [13].
One or more of these could be responsible for the binding
of WASp to Fyn. Patients with WAS or X-linked thrombo-
cytopenia have missense, nonsense or frameshift mutations
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Figure 6
In vivo association between WASp and SH3-
containing proteins. (a) Sf9 cells were
infected with a baculovirus encoding WASp,
alone or in combination with baculoviruses
encoding c-Fgr, Fyn or c-Src. Cell lysates
were incubated with immunoprecipitating
antibodies directed against WASp (JD1),
c-Fgr (a-c-Fgr), Fyn (a-Fyn) or c-Src (a-c-Src),
or with non-immunoprecipitating anti-WASp
antibodies (SK3). Immunoprecipitates were
analyzed by immune complex kinase assay
followed by SDS–PAGE, and phosphorylated
proteins were visualized by autoradiography.
The major co-precipitating phosphoproteins
are indicated by the arrow. (b) Sf9 cells were
co-infected with baculoviruses encoding
WASp and Fyn. Immunoprecipitates were
prepared from cell lysates using anti-Fyn or
anti-WASp (JD1) antisera, and were
subjected to SDS–PAGE and immunoblotted
using the anti-Fyn antiserum. The position of
Fyn is indicated by the arrow.
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that are found throughout the WAS gene, but are concen-
trated in the first two exons [16,17]. None of the mutations
characterized to date lies within the proline-rich motifs that
are candidates for SH3 binding. However, if SH3 binding
can be mediated by more than one of these motifs, it is
possible that a mutation in any one of them would not have
any functional consequences. 
A number of studies have shown that haematopoietic cells
from WAS patients have morphological abnormalities,
suggesting that WASp may involved in maintaining or reg-
ulating cytoskeletal structure. For example, platelets from
WAS patients are abnormal in size and shape, and throm-
bocytopenia seems to result from to their accelerated
destruction [24]; T-cells from WAS patients have a
decrease in the size and density of microvillus surface pro-
jections [25]. Cdc42 is involved in regulating cytoskeletal
structure, and its interaction with WASp may be important
in this context [14,15]. However, c-Src family PTKs,
including Fyn, also seem to have important roles in regu-
lating cytoskeletal changes in both haematopoietic [26]
and non-haematopoietic [27,28] cells, and it is possible
that the interaction between WASp and c-Src family
PTKs is involved in signalling pathways that regulate the
cytoskeleton in haematopoietic cells.
Other work suggests that WASp has a role in signalling
pathways that regulate proliferative responses of lympho-
cytes, and our data raise the possibility that this involves an
interaction with Fyn. For example, cross-linking of the B-
cell receptor on B cells from WAS patients fails to induce
cell proliferation or tyrosine phosphorylation of cellular
proteins, including PLC-g1 [29], and there is good evi-
dence that Fyn is involved in signalling mediated by the B-
cell receptor [12]. Likewise, T-cells from WAS patients fail
to proliferate in an oxidative mitogenesis assay [30], and
Fyn has an important role in signal transduction mediated
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Figure 7
Co-precipitation of WASp and a protein kinase from U937 cells.
Lysates of U937 cells, untreated or treated with phorbol 12-myristyl
13-acetate (PMA), were incubated with immunoprecipitating JD1 anti-
WASp antibodies or non-immunoprecipitating SK3 anti-WASp
antibodies. Immunoprecipitates were analyzed by immune complex
kinase assay and phosphorylated proteins were visualized by
autoradiography. The large arrow indicates a phosphoprotein that co-
migrates with Fyn and is found specifically in immunoprecipitates
containing WASp. The small arrow indicates a smaller phosphoprotein
that is enriched in PMA-treated U937 cells and is present in negative-
control SK3 immunoprecipitates that do not contain WASp.
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Figure 8
Co-precipitation of WASp and Fyn from U937 cells. Total cell lysate
from U937 cells (lysate) and U937 cell lysate immunoprecipitated with a
mouse anti-Fyn monoclonal antibody (IP a-Fyn) or with JD1 rabbit anti-
WASp antiserum (IP a-WASp) were subjected to SDS–PAGE and
immunoblotted using the mouse anti-Fyn monoclonal antibody. The large
arrow indicates that Fyn protein is present in U937 cells, in anti-Fyn
immunoprecipitates and in anti-WASp immunoprecipitates. The
secondary antibody used for immunoblotting recognizes the heavy chain
of the mouse anti-Fyn monoclonal antibody, which migrates slightly
faster than Fyn, as indicated by the small arrow. However, the secondary
antibody does not cross-react with the rabbit anti-WASp antiserum, as
indicated by a control in which cell lysis buffer was immunoprecipitated
with the anti-WASp antiserum (IP a-WASp, no lysate).
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by the T-cell receptor [11], which involves tyrosine phos-
phorylation of PLC-g1 [31–33]. It is therefore possible that
interaction between WASp and Fyn is important for sig-
nalling downstream of the B- and T-cell receptors, as well
as for signalling events in other haematopoietic lineages.
Materials and methods
Cell lines
U937 cells were maintained in RPMI 1640 medium supplemented with
5 % fetal bovine serum. To induce differentiation towards the monocytic
lineage, exponentially growing U937 cells were sub-cultured at a density
of 5 × 105 cells ml–1 and treated with PMA (Sigma) at a final concentra-
tion of 10 ng ml–1 for 24 h. CHRF-288-11 cells were maintained in RPMI
1640 medium supplemented with 20 % heat-inactivated horse serum.
Preparation of cell and tissue lysates
Cells were washed in ice-cold phosphate-buffered saline and lysed in
10 mM Tris–HCl, (pH 7.5), 1 % (v/v) Triton X-100, 150 mM NaCl,
5 mM EDTA, 50 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 5 mM
benzamidine, 1 mM NaVO4 and 100 kallikrein inhibitor units ml–1 of
aprotinin (lysis buffer). Protein concentrations were measured using the
Bradford assay.
GST–SH3 fusion protein affinity chromatography
We previously reported the construction and expression of a panel of
GST–SH3 fusion proteins [4]. Affinity matrices were prepared by immo-
bilising GST alone or GST–SH3 fusion proteins on glutathione–
Sepharose beads (Pharmacia), as described [34]. Freshly prepared cell
or tissue lysates were placed on ice for 20 min, clarified by centrifuga-
tion at 15 000 rpm for 20 min and incubated with the affinity matrices for
2 h at 4 °C. After extensive washing, bound proteins were released by
boiling in SDS sample buffer and analysed by SDS–PAGE. SH3-
binding proteins were visualized by silver or Coomassie staining.
Purification and sequencing of SH3-binding proteins
Glutathione–Sepharose beads pre-loaded with approximately 50 mg of
GST–Fgr-SH3 fusion protein were incubated with lysate from 2 × 108
U937 cells for 2 h at 4 °C. After extensive washing in lysis buffer,
bound proteins were fractionated by SDS–PAGE. Proteins were visual-
ized by Coomassie staining and the two bands in the 65/68 kDa
doublet were excised separately and digested with lysylpeptidase C.
Peptides were separated by reverse-phase high-pressure liquid chro-
matography (Hewlett Packard 1090M) and sequenced using a modi-
fied Applied Biosystems 477A Sequencer [35].
Antibodies
Rabbits were immunized with a carboxy-terminal peptide, correspond-
ing to amino-acids 487–501 of WASp [13], coupled to activated
keyhole limpet hemocyanin. Immunoreactive serum SK3 was selected
for further use and was affinity purified on a carboxy-terminal
peptide–Actigel affinity matrix. A second anti-WASp antiserum (JD1),
was raised against a GST–WASP fusion protein containing amino
acids 48–321 of WASp [15]. A mouse monoclonal anti-Fyn antibody
was obtained from Santa-Cruz Biotechnology.
Immunoprecipitation and immune complex kinase assays
Freshly prepared cell lysates were incubated for 2 h at 4 °C with the
specific primary antibody, and then for 1 h at 4 °C with protein
A–Sepharose beads. In some experiments, cell lysates were incubated
with primary antibody that had been covalently cross-linked to protein
A–Sepharose beads. Immune complexes were collected by centrifuga-
tion, washed extensively with lysis buffer and boiled in SDS sample
buffer for prior to analysis by SDS–PAGE.
Protein-tyrosine kinases were detected by immune complex kinase
assay. After immunoprecipitation and extensive washing in lysis buffer,
the beads were washed once in kinase buffer (50 mM Hepes (pH 7.5),
150 mM NaCl, 2 mM MnCl2, 12 mM MgCl2, 100 mM NaVO4, 10 % v/v
glycerol and 1 mM DTT) and 10 mCi g-[32P]ATP was added. Samples
were incubated at room temperature for 15 min and then analyzed by
SDS–PAGE followed by autoradiography.
Immunoblotting
Proteins were transferred from SDS–PAGE gels by electroblotting on
to polyvinylidene difluoride (PVDF) membrane (Millipore, Massachu-
setts). Membranes were blocked by incubation for 1 h at room temper-
ature in blocking buffer, consisting of phosphate-buffered saline (PBS),
0.05 % (v/v) Tween and 4 % (w/v) dried milk. Membranes were then
incubated with primary antibody (affinity purified SK3 anti-WASp at a
dilution of 1/1000 in blocking buffer) for 2 h at room temperature,
washed in blocking buffer, and incubated with horseradish peroxidase-
conjugated anti-rabbit Ig (Amersham) for 1 h at room temperature.
Finally, membranes were washed twice in blocking buffer and once in
PBS containing 0.1% (v/v) Tween, and immunoreactive proteins were
detected by enhanced chemiluminescence (Amersham).
Generation of baculoviruses.
Full-length human WAS cDNA [13] and human c-fgr cDNA [36] were
cloned into the pAcSG2 and pAc36C baculovirus transfer vectors
(PharMingen), respectively. Sf9 insect cells were transfected with the
transfer vectors and viral genomic DNA (Baculo Gold) using lipofectin.
Recombinant viruses were amplified and insect cells infected as
described [4].
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